Overview

Global Healthcare Distribution Market is estimated to value over USD 4.5 billion by 2026 end and register a CAGR of over 13% during the forecast period 2019 to 2026.

The worldwide market for healthcare distribution involves storage and transportation of pharmaceutical products from production units to the wholesalers, patients and hospitals. Manufacturers of pharmaceutical goods share strong ties with the suppliers of 3PL to allow the uptake of effective reasonably priced metrics.

The healthcare industry is mandated to follow the stringent public regulations due to the  pharmaceutical goods being made available to patients in usable modes and the rigid guidelines ensures their safety records are accomplished by healthcare pharmaceutical goods. In different circumstances, businesses may also wish to carry out their distribution endeavours through outsourcing. The global healthcare distribution market growth is primarily driven by the high volume of chronic illness, lucrative investments in research and development endeavours, growing emphasis on generics, and innovations in the medical equipment industry.

The pharmaceutical goods distribution services segment holds the maximum global healthcare distribution market share primarily because of the boost in the production of pharmaceutical endeavours, growing research and development expenditure, the deploying of pharmaceutical manufacturing to Asian nations and the implementation of new manufacturing units by international companies in new geographical locations.

Market analysis shows that the retail pharmacies hold the largest market shares. In fact, these pharmacies receive a significant number of prescriptions on a day-to-day basis. Furthermore, the US as well as other developed nations, have enacted programs to provide cost-effective healthcare for citizens. Due to this reason, there has been a robust growth in the number of prescriptions in retail pharmacies.

Key players that dominate the healthcare distribution market includes FFF Enterprises (US), Owens & Minor, Inc. (US), McKesson Corporation (US), Mutual Drug (US), CuraScript SD (US), Rochester Drug Cooperative, Inc. (US),  Medline Industries (US), Patterson Companies Inc. (US), AmerisourceBergen Corporation (US), Morris and Dickson Co., LLC (US), Henry Schein Inc. (US), Smith Drug Company (US), Cardinal Health, Inc. (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Henry Schein Inc. (US), PHOENIX Group (Germany), and KeySource Medical, Inc. (US).

Global Healthcare Distribution Services Market Segmentation:

By Type

•    Over-The-Counter Drugs/Vitamins
•    Brand-Name/Innovator Drugs
•    Generic Drugs
•    Medical Device Distribution Services
•    Biopharmaceutical Product Distribution Services
•    Monoclonal Antibodies
•    Vaccines
•    Recombinant Proteins
•    Blood and Blood Products
•    Other Products

By End User

•     Retail Pharmacies
•     Hospital Pharmacies
•     Other End Users

By Region

• Europe
• North America
• Asia Pacific
• Rest of the World

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the healthcare distribution market by type, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
• To forecast and evaluate micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record , evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

1.3 Market Scope 

        1.3.1 Markets Covered

        1.3.2 Years Considered for the Study

1.4 Currency 

1.5 Limitations 

1.6 Stakeholders 

2 Research Methodology 

2.1 Research Data 

        2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

        2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

                 2.1.2.2 Key Industry Insights

2.2 Market Size Estimation 

        2.2.1 Bottom-Up Approach

        2.2.2 Top-Down Approach

2.3 Market Breakdown and Data Triangulation 

2.4 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

4.1 Healthcare Distribution Services: Market Overview 

4.2 North America: Healthcare Distribution Services Market, By Type (2018) 

4.3 Europe: Healthcare Distribution Services Market, By End User (2018) 

4.4 Healthcare Distribution Services Market: Geographic Growth Opportunities 

5 Market Overview 

5.1 Introduction 

5.2 Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 High Incidence and Large Economic Burden of Chronic Diseases

                 5.2.1.2 Favorable R&D Investment Scenario and Subsequent Increase in Drug Launches

                 5.2.1.3 Growth of Track & Trace Solutions

                 5.2.1.4 Growing Importance of Generics

                 5.2.1.5 Growth of the Medical Devices Industry

        5.2.2 Opportunities

                 5.2.2.1 Growth in the Biosimilars Market

                 5.2.2.2 Emerging Markets

                 5.2.2.3 Increasing Specialty Drug Dispensing

                 5.2.2.4 Increasing Uptake of Biopharmaceuticals

        5.2.3 Challenges

                 5.2.3.1 Pricing Pressures

6 Healthcare Distribution Services Market, By Type 

6.1 Introduction 

6.2 Pharmaceutical Product Distribution Services 

        6.2.1 Over-The-Counter Drugs/Vitamins

                 6.2.1.1 Sales of OTC Drugs have Risen Due to Innovations, Promotion of Self-Medication, and Increased Access

        6.2.2 Brand-Name/Innovator Drugs

                 6.2.2.1 Rising Demand for Prescription Drugs to Support the Growth of This Market Segment

        6.2.3 Generic Drugs

                 6.2.3.1 Government Initiatives for Promoting the Usage of Generics to Support the Growth of This Market Segment

6.3 Medical Device Distribution Services 

6.4 Biopharmaceutical Product Distribution Services 

        6.4.1 Monoclonal Antibodies

                 6.4.1.1 Increasing Incidence of Cancer to Support the Growth of This Market Segment

        6.4.2 Vaccines

                 6.4.2.1 Growing Prevalence of Infectious Diseases has Boosted Vaccine Development

        6.4.3 Recombinant Proteins

                 6.4.3.1 Growing Applications of Recombinant Proteins in Biopharmaceuticals to Drive the Growth of This Market Segment

        6.4.4 Blood and Blood Products

                 6.4.4.1 Increasing Number of Blood Donations and Blood Transfusions to Support the Growth of This Market Segment

        6.4.5 Other Products

7 Healthcare Distribution Services Market, By End User 

7.1 Introduction 

7.2 Retail Pharmacies 

        7.2.1 Large Volume of Prescriptions to Increase the Demand for Healthcare Distribution Services

7.3 Hospital Pharmacies 

        7.3.1 Significant Number of Inpatient Visits and Requirement of Large Volume of Drugs By Hospitals to Drive the Healthcare Distribution Services Market for Hospital Pharmacies

7.4 Other End Users 

8 Healthcare Distribution Services Market, By Region 

8.1 Introduction 

8.2 North America 

        8.2.1 US

                 8.2.1.1 US Dominates the North American Healthcare Distribution Services Market

        8.2.2 Canada

                 8.2.2.1 Rising Prevalence of Chronic Diseases and Increasing Market for Specialty Drugs Will Drive Market Growth in Canada

8.3 Europe 

        8.3.1 Germany

                 8.3.1.1 Germany Accounted for the Largest Share of the European Healthcare Distribution Services Market in 2018

        8.3.2 France

                 8.3.2.1 Presence of Leading Pharmaceutical Companies in the Country Will Drive Market Growth in France

        8.3.3 UK

                 8.3.3.1 Growth in the Pharmaceuticals Market and Increase in Research Activity Will Drive Market Growth in the UK

        8.3.4 Rest of Europe

8.4 Asia Pacific 

        8.4.1 China and India are the Fastest-Growing Markets in the APAC

8.5 Rest of the World 

9 Competitive Landscape

9.1 Introduction 

9.2 Healthcare Distribution Services Market Share Analysis 

9.3 Competitive Scenario 

10 Company Profiles 

  10.1 McKesson Corporation 

          10.1.1 Business Overview

          10.1.2 Solutions Offered

          10.1.3 Recent Developments

          10.1.4 MnM View

  10.2 Cardinal Health, Inc. 

          10.2.1 Business Overview

          10.2.2 Services Offered

          10.2.3 Recent Developments

          10.2.4 MnM View

  10.3 AmerisourceBergen Corporation 

          10.3.1 Business Overview

          10.3.2 Services Offered

          10.3.3 Recent Developments

          10.3.4 MnM View

  10.4 Owens & Minor, Inc. 

          10.4.1 Business Overview

          10.4.2 Services Offered

          10.4.3 Recent Developments

          10.4.4 MnM View

  10.5 Morris & Dickson Co. L.L.C. 

          10.5.1 Business Overview

          10.5.2 Services Offered

          10.5.3 Recent Developments

  10.6 Curascript Specialty Distribution 

          10.6.1 Business Overview

          10.6.2 Services Offered

          10.6.3 Recent Developments

  10.7 FFF Enterprises, Inc. 

          10.7.1 Business Overview

          10.7.2 Services Offered

          10.7.3 Recent Developments

  10.8 Medline Industries 

          10.8.1 Business Overview

          10.8.2 Services Offered

          10.8.3 Recent Developments

  10.9 Attain Med, Inc. 

          10.9.1 Business Overview

          10.9.2 Recent Developments

  10.10 Dakota Drug 

          10.10.1 Business Overview

          10.10.2 Recent Developments

Chapter 11 Research Finding and Conclusion 

Chapter 12  Research Methodology 

Chapter 13  Research Data Source

Tables

Figures